Involvement of cyclin-dependent kinase inhibitor p27(Kip1) in growth inhibition of endometrium in the secretory phase and of hyperplastic endometrium treated with progesterone

Molecular Human Reproduction

Volumn 4, Issue 9, 1998, Pages 899-905

  Shiozawa, Tanri ^a   Nikaido, Toshio ^a   Nakayama, Kuniaki ^a   Lu, Xin ^a   Fujii, Shingo ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cyclin; Endometrium; Ki 67; P27(Kip1); Progesterone

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; PROGESTERONE; PROTEIN P27;

ADULT; ARTICLE; CELL CYCLE; CELL PROLIFERATION; ENDOMETRIUM HYPERPLASIA; FEMALE; GROWTH REGULATION; HUMAN; HUMAN TISSUE; MENSTRUAL CYCLE; PRIORITY JOURNAL;

ADULT; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; ENDOMETRIUM; FEMALE; GROWTH INHIBITORS; HUMANS; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; MEDROXYPROGESTERONE 17-ACETATE; MENSTRUAL CYCLE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; STROMAL CELLS; TUMOR SUPPRESSOR PROTEINS;

EID: 0031684512     PISSN: 13609947     EISSN: None     Source Type: Journal    
DOI: 10.1093/molehr/4.9.899     Document Type: Article

References (29)

1. Amso, N.N., Crow, J. and Shaw, R.W. (1994) Comparative immunohistochemical study of oestrogen and progesterone receptors in the Fallopian tube and uterus at different stages of the menstrual cycle and the menopause. Hum. Reprod., 9, 1027-1037.
2. Kip1-deficient mice. Cell, 85, 733-744
3. Gerdes, J., Lemke, H., Baisch, H. et al. (1984) Cell cycle analysis of a cell proliferation-human nuclear antigen defined by the monoclonal antibody Ki-67. J. Immunol., 133, 1710-1715.
4. Giudice, L.C (1994) Growth factors and growth modulators in human uterine endometrium: their potential relevance to reproductive medicine Fertil. Steril., 61, 1-17.
5. Halevy, O., Novitch, B.C., Spicer, D.B. et al (1995) Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science, 267, 1018-1021.
6. Kip1 accumulation during the cell cycle. Science, 271, 1861-1864.
7. Kip1. Cell, 85, 721-732.
8. Lessey, B.A., Killam, A.P., Metzger, D.A. et al. (1988) Immunohistochemical analysis of human uterine estrogen and progesterone receptors throughout the menstrual cycle. J. Clin. Endocrinol. Metab., 67, 334-340.
9. Levy, C., Robel, P., Gautray, J.P. et al. (1980) Estradiol and progesterone receptors in human endometrium: normal and abnormal menstrual cycles and early pregnancy. Am. J. Obstet. Gynecol., 136, 646-651.
10. Li, S -F., Nakayama, K., Masuzawa, H. et al. (1993) The number of proliferating cell nuclear antigen positive cells in endometriotic lesions differs from that in the endometrium. Virchows Archiv A (Pathol. Anat.), 423, 257-263.
11. Li, S.-F., Shiozawa, T., Nakayama, K. et al. (1996) Stepwise abnormality of sex steroid hormone receptors, tumor suppressor gene products (p53 and Rb), and cyclin E in uterine endometrioid carcinoma. Cancer, 77, 321-329.
12. Loda, M., Cukor, B., Tam, S.W. et al. (1997) Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nature Med., 3, 231-234.
13. 1/S phosphorylation of the retinoblastoma protein is associated with an altered affinity for the nuclear compartment. Cell, 65, 381-393.
14. Kip1 display increased body size, multiorgan hyperplasia, retinal dysplasia, and pituitary tumors. Cell, 85, 707-720.
15. Noyes, R.W., Hertig, A.T. and Rock, J. (1950) Dating the endometrial biopsy. Fertil. Steril., 1, 3-25.
16. Nurse, P (1994) Ordering S phase and M phase in the cell cycle. Cell, 79, 547-550.
17. Pagano, M., Tam, S.W., Theodoras, A.M. et al. (1995) Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science, 269, 682-685.
18. Kip1 in muscle and other terminally differentiating cells. Science, 267, 1024-1027.
19. Pickarts, H., Beckmann, R., Fleige, B et al (1990) Steroid receptors and proliferative activity in non-neoplastic and neoplastic endometria. Virchows Archiv A, (Pathol. Anat.), 417, 163-171.
20. Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell, 78, 59-66.
21. Polyak, K., Kato, J.Y., Solomon, M.J. et al. (1994b) p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev., 8, 9-22.
22. 1 phase progression: cyclin on cue. Cell, 79, 551-555.
23. 1 cyclin-dependent kinases Genes Dev., 9, 1149-1163.
24. Shiozawa, T., Li, S.-F., Nakayama, K. et al. (1996) Relationship between the expression of cyclins/cyclin-dependent kinases and sex-steroid receptors/Ki-67 in normal human endometrial glands and stroma during the menstrual cycle. Mol. Hum. Reprod., 2, 745-752.
25. INK4 in human endometrioid-type endometrial carcinoma. Cancer, 80, 2250-2256.
26. Strauss III, J.F. and Gurpide, E. (1991) The endometrium: regulation and dysfunction. In Yen, S.S.C. and Jaffe, R.B. (eds), Reproductive Endocrinology. 3rd edn. W.B.Saundcrs and Co, Philadelphia, USA, 309 pp.
27. Tseng, L. and Mazzella, J. (1980) Cyclic changes of estradiol metabolic enzymes in human endometrium during the menstrual cycle. In Kimball, F.A. (ed.), The Endometrium. SP Medical and Scientific Books, New York, USA, 211 pp.
28. 1 cyclin-cdk protein kinase activity, is related to p21. Cell, 78, 67-74.
29. 1-S phase block induced by 1,25-dihydroxyvitamm D3 in HL60 cells. Cancer Res., 56, 264-267.